0001614107-22-000001.txt : 20221107 0001614107-22-000001.hdr.sgml : 20221107 20221107094703 ACCESSION NUMBER: 0001614107-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221107 DATE AS OF CHANGE: 20221107 EFFECTIVENESS DATE: 20221107 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Faraday Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001614107 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-464006 FILM NUMBER: 221364085 BUSINESS ADDRESS: STREET 1: 1616 EASTLAKE AVENUE E. STREET 2: SUITE 560 CITY: SEATTLE STATE: WA ZIP: 98102 BUSINESS PHONE: 2064528700 MAIL ADDRESS: STREET 1: 1616 EASTLAKE AVENUE E. STREET 2: SUITE 560 CITY: SEATTLE STATE: WA ZIP: 98102 D 1 primary_doc.xml X0708 D LIVE 0001614107 Faraday Pharmaceuticals, Inc. 1616 EASTLAKE AVENUE E. SUITE 560 SEATTLE WA WASHINGTON 98102 206-492-5310 DELAWARE Scion Pharmaceuticals, Inc. None Corporation true Mark Roth c/o Faraday Pharmaceuticals, Inc. 1616 Eastlake Avenue E., Suite 560 Seattle WA WASHINGTON 98102 Director Promoter Steven Gillis c/o Faraday Pharmaceuticals, Inc. 1616 Eastlake Avenue E., Suite 560 Seattle WA WASHINGTON 98102 Director Stephen Hill c/o Faraday Pharmaceuticals, Inc. 1616 Eastlake Avenue E., Suite 560 Seattle WA WASHINGTON 98102 Executive Officer Director Terrance McGuire c/o Faraday Pharmaceuticals, Inc. 1616 Eastlake Avenue E., Suite 560 Seattle WA WASHINGTON 98102 Director Lawrence Gozlan c/o Faraday Pharmaceuticals, Inc. 1616 Eastlake Avenue E., Suite 560 Seattle WA WASHINGTON 98102 Director Brian Blackman c/o Faraday Pharmaceuticals, Inc. 1616 Eastlake Avenue E., Suite 560 Seattle WA WASHINGTON 98102 Executive Officer Simon Tulloch c/o Faraday Pharmaceuticals, Inc. 1616 Eastlake Avenue E., Suite 560 Seattle WA WASHINGTON 98102 Executive Officer Patrick Rock c/o Faraday Pharmaceuticals, Inc. 1616 Eastlake Avenue E., Suite 560 Seattle WA WASHINGTON Seattle Executive Officer Ronald Kierpa c/o Faraday Pharmaceuticals, Inc. 1616 Eastlake Avenue E., Suite 560 Seattle WA WASHINGTON Seattle Executive Officer Pharmaceuticals Decline to Disclose 06b false 2022-10-24 false true false 0 102826124 52826124 50000000 false 3 0 0 0 false Faraday Pharmaceuticals, Inc. /s/ Brian Blackman Brian Blackman Chief Financial and Business Officer 2022-11-07